A Bionic "Trojan Horse"-like Nanovesicle Delivery System Hybridized with BCG Cytoplasmic Membrane and Melanoma Cell Membrane for Cancer Immunotherapy.

Pharmaceutics · 2025 · PMC12030220 · PMID 40284501

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

As is shown in Figure 5 E,F, the B16-NVs, BCG-NVs, and BB-NVs groups showed a trend of progressively higher mature T cell ratios.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.